Partner news
News
Partner news
L'engagement de Janssen France dans l'IA et la génomique
Read full storyPartner news
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
Read full storyPartner news
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
Read full storyPartner news
Inivata Announces Strategic Collaboration and Investment from NeoGenomics
Read full storyPartner news
Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics
Read full storyPartner news
Cala Health Raises $50 Million Series C Funding
Read full storyPartner news
TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform
Read full storyPartner news
Zebra Medical Vision Receives FDA Approval for World's First AI Chest X-ray Triage Product
Read full storyJNJ Press releases
GCV Powerlist 2018: #5 Tom Heyman
Read full storyPartner news
GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing
Read full storyJNJ Press releases
Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimen
Read full storyPartner news
BRIEF-Provention Bio Files For IPO Of Up To $50 Million
Read full storyPartner news
Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
Read full storyJNJ Press releases